Holen Sie sich die Stockscreener-App
25.96
4.70%
-1.28
Handel nachbörslich:
25.96
Schlusskurs vom Vortag:
$27.24
Offen:
$27.01
24-Stunden-Volumen:
5.14M
Relative Volume:
1.54
Marktkapitalisierung:
$4.80B
Einnahmen:
$550.17M
Nettoeinkommen (Verlust:
$201.35M
KGV:
25.96
EPS:
1
Netto-Cashflow:
$232.07M
1W Leistung:
-26.35%
1M Leistung:
-40.72%
6M Leistung:
-58.01%
1J Leistung:
-65.36%
1-Tages-Spanne:
$25.92
$27.43
1-Wochen-Bereich:
$23.66
$35.83
52-Wochen-Spanne:
$23.66
$79.97
Doximity Inc Stock (DOCS) Company Profile
Firmenname
Doximity Inc
Sektor
Branche
Telefon
(650) 549-4330
Adresse
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, TEM, BTSG, HQY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
25.96 | 5.03B | 550.17M | 201.35M | 232.07M | 1.00 |
|
VEEV
Veeva Systems Inc
|
177.04 | 30.74B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
53.61 | 9.94B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
40.06 | 7.10B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
76.92 | 6.69B | 1.15B | 96.70M | -161.99M | 1.09 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-06 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2026-01-20 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2026-01-09 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-08 | Hochstufung | Truist | Hold → Buy |
| 2025-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-21 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-10-27 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-10-10 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-10-01 | Herabstufung | Goldman | Neutral → Sell |
| 2025-07-09 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-06-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-02-07 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-15 | Eingeleitet | Goldman | Neutral |
| 2024-11-14 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-08-09 | Hochstufung | Needham | Hold → Buy |
| 2024-07-18 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-02 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-08-09 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-08-09 | Herabstufung | Needham | Buy → Hold |
| 2023-08-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | Eingeleitet | Wells Fargo | Overweight |
| 2022-10-24 | Eingeleitet | Evercore ISI | In-line |
| 2022-10-13 | Eingeleitet | BTIG Research | Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-07-28 | Eingeleitet | Berenberg | Buy |
| 2022-05-18 | Bestätigt | BofA Securities | Neutral |
| 2022-05-18 | Bestätigt | Goldman | Buy |
| 2022-05-18 | Bestätigt | Guggenheim | Buy |
| 2022-05-18 | Bestätigt | Jefferies | Buy |
| 2022-05-18 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Bestätigt | Needham | Buy |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-04 | Eingeleitet | BofA Securities | Neutral |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-11-10 | Bestätigt | Canaccord Genuity | Buy |
| 2021-11-10 | Bestätigt | Goldman | Neutral |
| 2021-11-10 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-11-10 | Bestätigt | Needham | Buy |
| 2021-11-10 | Bestätigt | Piper Sandler | Overweight |
| 2021-08-26 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-07-19 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-19 | Eingeleitet | Goldman | Neutral |
| 2021-07-19 | Eingeleitet | JP Morgan | Overweight |
| 2021-07-19 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-07-19 | Eingeleitet | Raymond James | Outperform |
| 2021-07-19 | Eingeleitet | SVB Leerink | Outperform |
| 2021-07-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Doximity Inc Aktie (DOCS) Neueste Nachrichten
Doximity Stock: Growth Outlook Is Murky (NYSE:DOCS) - Seeking Alpha
Barclays Maintains Doximity(DOCS.US) With Buy Rating, Cuts Target Price to $38 - 富途牛牛
Barclays Has Lowered Expectations for Doximity (NASDAQ:DOCS) Stock Price - MarketBeat
Allianz Asset Management GmbH Invests $5.72 Million in Doximity, Inc. $DOCS - MarketBeat
Doximity (NASDAQ:DOCS) User Engagement Trends And Nyse Composite Market Reaction Explained - Kalkine Media
Quarterly Trades: Why is Doximity Inc stock going upJuly 2025 Setups & Technical Pattern Alert System - baoquankhu1.vn
Doximity (NASDAQ:DOCS) Price Target Lowered to $34.00 at Mizuho - MarketBeat
Mizuho lowers Doximity stock price target to $34 on pharma marketing delays - Investing.com Nigeria
Doximity (NYSE:DOCS) Raised to "Strong-Buy" at Canaccord Genuity Group - MarketBeat
Doximity, Inc. (DOCS) Stock Analysis: A Healthcare Tech Leader With 60% Upside Potential - DirectorsTalk Interviews
William Blair Dumps $21 Million of Healthcare Platform Doximity Stock - AOL.com
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Chevron, Domino’s Pizza, Doximity, Exact Sciences, Intel, NetApp, StubHub, Toast, and More - AOL.com
William Blair Dumps $21 Million of Healthcare Platform Doximity Stock - The Motley Fool
Here Are Monday’s Top Wall Street Analyst Research Calls: Autozone, Doximity, Li Auto, Oracle, Robinhood Markets, Roblox, SoFi Technolgy, Terawulf and More - AOL.com
Canaccord Genuity Upgrades Doximity to Buy From Hold, Adjusts Price Target to $34 From $48 - marketscreener.com
Canaccord Genuity upgrades Doximity stock to Buy on valuation By Investing.com - Investing.com UK
Canaccord Genuity upgrades Doximity stock to Buy on valuation - Investing.com
Assessing Doximity (DOCS) Valuation After A Sharp Pullback And Ongoing Profitability - Yahoo Finance
Doximity (DOCS) Earnings Call: AI, Buybacks and Growth - TipRanks
Doximity (NYSE:DOCS) Rating Increased to Moderate Buy at Needham & Company LLC - MarketBeat
Doximity Stock (-17%): Weak Guidance Sparks an Institutional Sell-Off - Trefis
JPMorgan upgrades Doximity stock rating to Neutral from Underweight By Investing.com - Investing.com Nigeria
Truist Securities lowers Doximity stock price target to $37 on growth concerns By Investing.com - Investing.com South Africa
Needham lowers Doximity stock price target to $55 on mixed earnings - Investing.com UK
Doximity (DOCS) Stock Plummets 17% on Weak Guidance and AI Cost Surges - FinancialContent
Doximity stock dives as Q4 outlook rattles investors despite $500 million buyback - TechStock²
Doximity, Inc.'s (NYSE:DOCS) Popularity With Investors Under Threat As Stock Sinks 27% - simplywall.st
Doximity (NYSE:DOCS) Shares Gap DownWhat's Next? - MarketBeat
Doximity Stock Falls Despite Q3 Earnings & Revenues Beat Estimates - Yahoo Finance
Why Doximity stock plummeted today - MSN
This Roku Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday - Benzinga
Why Doximity Stock Plummeted Today - AOL.com
Doximity's Soft Fiscal Q4 Guidance Adds to Investor Concerns, Morgan Stanley Says - marketscreener.com
Doximity stock price target lowered to $25 by BMO Capital on near-term headwinds - Investing.com Nigeria
Doximity (NASDAQ:DOCS) Shares Gap Down After Analyst Downgrade - MarketBeat
These Stocks Are Today’s Movers: Amazon, Strategy, Novo Nordisk, Molina, Stellantis, Impinj, Doximity, and More - Barron's
Truist Cuts Price Target on Doximity to $37 From $62, Keeps Buy Rating - marketscreener.com
Piper Sandler lowers Doximity stock price target to $40 on slow bookings By Investing.com - Investing.com South Africa
Why Did DOCS Stock Plunge 35% In Pre-Market Today? - Asianet Newsable
Piper Sandler lowers Doximity stock price target to $40 on slow bookings - Investing.com
Doximity (DOCS) Q3 2026 Earnings Call Transcript - AOL.com
Needham lowers Doximity stock price target to $55 on mixed earnings By Investing.com - Investing.com South Africa
DOCS Q4 Deep Dive: AI Momentum Overshadowed by Pharma Budget Delays and Cautious Guidance - Finviz
Doximity (NASDAQ:DOCS) Upgraded to Neutral at JPMorgan Chase & Co. - MarketBeat
Needham & Company LLC Issues Pessimistic Forecast for Doximity (NASDAQ:DOCS) Stock Price - MarketBeat
Doximity (NASDAQ:DOCS) Given New $37.00 Price Target at Truist Financial - MarketBeat
BTIG Research Cuts Doximity (NASDAQ:DOCS) Price Target to $50.00 - MarketBeat
Doximity, Inc. (NYSE:DOCS) Q3 2026 Earnings Call Transcript - Insider Monkey
DOCS: Needham Lowers Price Target but Maintains Buy Rating | DOCS Stock News - GuruFocus
Finanzdaten der Doximity Inc-Aktie (DOCS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.98%
1.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):